# EDGAR Filing Document

**Accession Number:** 0001100663
**File Stem:** 0001752724-23-069329
**Filing Date:** 2023-3
**Character Count:** 56167
**Document Hash:** 2d84f516d424694108f6349195546e61
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-069329.hdr.sgml**: 20230328

**ACCESSION NUMBER**: 0001752724-23-069329

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230328

**DATE AS OF CHANGE**: 20230328

**PERIOD START**: 20230430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iSHARES TRUST
- **CENTRAL INDEX KEY:** 0001100663
- **IRS NUMBER:** 943351276
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09729
- **FILM NUMBER:** 23767554

**BUSINESS ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** (415) 670-2000

**MAIL ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ISHARES TRUST
- **DATE OF NAME CHANGE:** 19991213

## Series and Classes Contracts Data

### iShares U.S. Healthcare ETF (Series ID: S000004324)

| Class ID   | Class Name                  | Ticker Symbol   |
|:---|:---|:---|
| C000012054 | iShares U.S. Healthcare ETF | IYH             |

## Nport-Ex

# Schedule of Investments (unaudited)

January 31, 2023

**iShares® U.S. Healthcare ETF** (Percentages shown are based on Net Assets)

| Security | Shares | Value |
| --- | --- | --- |
| Common Stocks |  |  |
| Biotechnology- 18.0% |  |  |
| Schedule of Investments |  |  |
| Alnylam Pharmaceuticals, Inc. (a) | 1,118,878 | $165,314,224 |
| Amgen, Inc. | 77,741 | 17,600,562 |
| Biogen, Inc. (a) | 338,050 | 85,323,820 |
|  | 90,671 | 26,376,194 |

| Security | Shares | Value |
| --- | --- | --- |
| Health Care Providers & Services (continued) |  |  |
| Amedisys, Inc. (a)(b) | 20,356 | $1,967,611 |
| Cardinal Health, Inc. | 165,726 | 12,802,488 |
| Centene Corp. (a) | 859,668 | 27,500,783 |
| Chemed Corp. | 3,228 | 4,652,432 |
| Cigna Corp. | 189,491 | 60,006,115 |
| DaVita, Inc. (a)(b) | 35,300 | 2,908,367 |

SCHEDULE OF INVESTMENTS

1

2

(unaudited) (continued)

January 31, 2023

| BioMarin Pharmaceutical, Inc. (a) | 116,706 | 13,462,037 |
| --- | --- | --- |
| Security | Shares | Value |
| Exact Sciences Corp. (a) | 110,475 | 7,459,272 |
| Exotics, Inc. (a) | 199,786 | 3,520,229 |
| Pharmaceuticals (continued) | 794,695 | 66,706,698 |
| Galaxie Sciences, Inc. | 780,319 | 9,316,339 |
| Horizon Therapeutics PLC (a) | 140,001 | 15,360,810 |
| Incyte Corp. (a) | 115,395 | 9,222,730 |
| Ionis Pharmaceuticals, Inc. (a) | 89,528 | 9,222,730 |
| Total Long-Term Investments - 99.7% | 28,321 | 1,512,625 |
| Mo (Cost: $2,946,963,845) | 210,042 | 3,289,748,620 |

| Electro-Ve | 158,606 | 76,301,474 |
| --- | --- | --- |
| Encompass Health Corp. | 62,097 | 3,877,958 |
| Short-Term Securities | 31,048 | 476,897 |
| Guardant Health, Inc. (a) | 61,536 | 1,934,076 |
| Money Market Funds - 2.0% | 136,572 | 34,835,420 |
| Hilltops, Inc. | 85,393 | 7,356,607 |
| Hilltops, Inc. (Cash Funds, Institutional, SL Agency) | 61,977,688 | $46,145,726 |
| Huntington, Inc. | 56,006 | 14,120,233 |
| Liberty, Inc. (Cash Funds, Institutional, SL Agency Shares) | 4,385,509 | 11,698,669 |
| Mo (Cost: $2,946,963,845) |  |  |

(unaudited) (continued)

January 31, 2023

| Natera, Inc. (a) | 61,991 | 2,661,274 | Total Short-Term Securities - 2.0% | 73,644 | 2,140,095 |
| --- | --- | --- | --- | --- | --- |
| Neptune, Inc. (a) | 59,930 | 5,648,038 | Total Short-Term Securities - 2.0% | 73,644 | 2,140,095 |
| Serious inputs are used in determining the fair value of financial instruments. These inputs are categorized into a fair value hierarchy of financial instruments. | 49,345 | 538,354 | Quoted Diagnostics, Inc. | 71,786 | 10,658,785 |
| Investments, Inc. (a) | 65,616 | 49,767,767 | Total Investments - 101.7% | 51,373 | 1,462,076 |
| Investments, Inc. (a) | 65,616 | 49,767,767 | Super Investing, Inc. (S&P) | 51,373 | 1,462,076 |
| Regeneron Pharmaceuticals, Inc. (a) | 65,616 | 49,767,767 | Total Investment - 101.7% | 67,209 | 3,344,895,175 |
| Sample, Inc. (a) | 65,616 | 49,767,767 | Total Investment - 101.7% | 67,209 | 3,344,895,175 |
| Sample, Inc. (a) | 65,616 | 49,767,767 | Total Investment - 101.7% | 67,209 | 3,344,895,175 |
| Sample, Inc. (a) | 65,616 | 49,767,767 |  |  |  |
| Sample, Inc. (a) | 65,616 | 49,767,767 |  |  |  |
| Sample, Inc. (a) | 65,616 | 49,767,767 |  |  |  |
| Sample, Inc. (a) | 65,616 | 49,767,767 |  |  |  |

![img-0.jpeg](img-0.jpeg)

Schedule of Investments

iShares® U.S. Healthcare ETF

# Fair Value Hierarchy as of Period End

Level 3 - Unobservable inputs based on the best information available in the circumstances. Unobservable inputs are not available (including the Valuation Committee's assumptions used in determining the fair value of financial instruments). All or a portion of this security is on loan. 73,493 1,425,764
Chemicals- 0.0%
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for financial assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is created for instruments categorized in Level 3.
The fair value hierarchy is not available for all into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is established based on the lowest level input that is significant in its entirety. Investments classified within Level 3 have significant unobservable inputs (Level 3 and the Valuation Committee in determining the price for Fair Value Investments. The Schedule of Investments is available only or debt issued by privately held companies. Investment in assets considered to be affiliate(s) of the Fund during the period ended January 31, 2023 for purposes of Section 2(a)(3) of the Investment Company Act of

SCHEDULE OF INVESTMENTS

3

| or funds. There may not be a secondary market, and/or there are a limited number of investments. The categorization of a value determined for financial instruments is based on the funding transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities. For information about the Fund's policy regarding valuation of financial instruments, refer to its most recent financial statements. | 100,743 | 45,734,773 | 100,743 | 45,734,773 | 100,743 | 45,734,773 | 100,743 | 45,734,773 | 100,743 | 45,734,773 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cooper Companies, Inc. (The) | 30,724 | 10,720,525 | 30,724 | 10,720,525 | 30,724 | 10,720,525 | 30,724 | 10,720,525 | 30,724 | 10,720,525 |
| The following table summarizes the Fund's financial instruments categorized in the fair value hierarchy. The breakdown of the Fund's financial instruments is as follows: | 100,787 | 26,108,221 | 100,787 | 26,108,221 | 100,787 | 26,108,221 | 100,787 | 26,108,221 | 100,787 | 26,108,221 |
| Edwards Lifesciences Corp.(a) | 390,951 | 29,985,942 | 390,951 | 29,985,942 | 390,951 | 29,985,942 | 390,951 | 29,985,942 | 390,951 | 29,985,942 |
| Enovis Corp.(b) | Value at Purchases | 32,005 | Proceeds | 2,018,755 | 2,018,755 | 2,018,755 | 2,018,755 | 2,018,755 | 2,018,755 | 2,018,755 |
| Affiliated Group | Value at Cost | 102,909 | from Sale | 4,012,422 | (Loss) | 4,012,422 | (Loss) | 4,012,422 | (Loss) | 4,012,422 |
| Assets |  |  |  |  |  |  |  |  |  |  |

| BlackRock Care Technologies, Inc.(a) | 229,985 | 15,988,557 | Illumina, Inc.(a)(b) | 99,433 | 21,296,549 |
| --- | --- | --- | --- | --- | --- |
| Garage Corporation (Class A)(a) | 48,469 | 3,659,410 | IOVIA Holdings, Inc.(a)(b) | 117,349 | 26,921,034 |
| High Life Investments | $40,415,625 | $20,677,842(a) | 154,558 | 12,697,754 | 3,921 |
| Common Stock |  |  |  | 3,271,454,230 | 3,271,454,230 |
| BlackRock Life (a) | 12,834 | 2,479,914 | PerkinElmer, Inc. | 79,770 | 10,970,768 |
| International Securities |  |  |  |  |  |
| IDEX Corporation (a) | 51,991 | 24,981,675 | OAKDEN, Inc.(a) | 143,363 | 7,624,787 |
| Money Market Funds |  |  |  | 80,440,945 | 65,440,945 |
| InterCorp.(a)(b) | 2,957,000 | 1,367,609(a) | 43,520 | 12,504,166 | 34,956 |
| Integra LifeSciences Holdings Corp.(a) | 45,550 | 2,610,015 | 3,921 | 3,344,895,175 | 3,344,895,175 |
| InterCom Financial Instruments(b) | 223,013 | 54,792,064 | Syneos Health, Inc., Class A(b)(b) | 64,859 | 2,329,735 |
| Masimo Corp.(a)(b) | 30,110 | 5,121,109 | Thermo Fisher Scientific, Inc. | 247,706 | 141,274,163 |

| Liabilities |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- |
| Net amount purchased (sold) | 846,159 | 70,815,047 | Wage Pharmaceutical Services, Inc. | 46,834 | 12,406,639 |
| Net amount contracts |  |  |  |  |  |
| All of a certain represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments |  |  |  |  |  |
| No and from borrowers of securities | 22,542 | 5,644,742 |  |  | 408,867,767 |
| Performed, Inc. |  |  |  |  |  |
| Ombudsman Corp. | 30,827 | 2,630,000 | Pharmaceuticals | 29,776 |  |
| Derivative Financial Instruments Outstanding as of Period End |  |  |  |  |  |
| ResMed, Inc. | 91,386 | 20,869,821 | Bristol-Myers Squibb Co. | 1,348,278 | 97,952,397 |
| Performa, Inc. |  |  |  |  |  |
| Futures Contracts | 63,113 | 13,033,466 | Catalent, Inc. (a)(b) | 112,862 | 6,043,760 |
| Stryker Corp. | 222,413 | 56,450,644 | Elanco Animal Health, Inc. (a) | 281,183 | 3,860,643 |
| Tandem Diabetes Care, Inc. (a) | 40,351 | 1,643,900 | Eli Lilly & Co. | 533,437 | 183,582,243 |

| Teleflex, Inc. | 29,672 | 7,222,758 | Jazz Pharmaceuticals PLC (a) | 30,865 | 6,088,501 |
| --- | --- | --- | --- | --- | --- |
| Zimmer Biomet Holdings, Inc. | 132,696 | 16,897,509 | Johnson & Johnson | 1,669,441 | 4,222,000 |
| Description |  | 648,838,819 | Merck & Co., Inc. | 1,601,500 | (2,000,000) |
| Long Contracts |  |  | Contractors | 160,630 | 4,839,782 |
| Health Care Providers & Services- 19.2% |  |  | Organon & Co. | 85,131 | 3,185,602 |
| Acadia Healthcare Co., Inc. (a)(b) | 56,306 | 4,730,830 | Perrigo Co. PLC | 3,578,161 | 158,011,590 |
| agilon health, Inc. (a)(b) | 119,992 | 2,611,026 | Pfizer, Inc. | 235,214 | 9,218,037 |
|  |  |  | Royalty Pharma PLC, Class A |  |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** iShares Trust

- **b. Investment Company Act file number:** 811-09729

- **c. CIK number of Registrant:** 0001100663

- **d. LEI of Registrant:** 5493000860OXIC4B5K91

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 400 Howard Street

  - **City:** San Francisco

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-474-2737

**Item A.2. Information about the Series.**

- **a. Name of Series:** iShares U.S. Healthcare ETF

- **b. EDGAR series identifier (if any):** S000004324

- **c. LEI of Series:** 5493006NG08TW6EJIJ27

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-04-30

- **b. Date as of which information is reported:** 2023-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $3344626534.63

**Total Liabilities:** $56780772.73

**Net Assets:** $3287845761.90

**Cash Not Reported:** $52000.00

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000012054 | 4.93%                | -1.76%               | -1.39%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $5115711.72              | $151094136.82                              |
| Month 2  | $16378733.65             | $-79997653.12                              |
| Month 3  | $3988021.04              | $-53751234.61                              |

### Schedule of Portfolio Investments

| Name                                                                       | Title                                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| REGENERON PHARMACEUTICALS, INC.                                            | REGENERON PHARMACEUTICALS INC                     | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     65616 | NS      | $49767767.52  | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | CUSIP: 066922519<br>LEI: N/A                  | Long             | STIV             | RF                | US        |  55378574 | NS      | $55411800.70  | 1.69%             |  |  |  | No            |                  1 | On Loan: No      |
| STERIS PUBLIC LIMITED COMPANY                                              | STERIS PLC                                        | CUSIP: G8473T100<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     63113 | NS      | $13033465.63  | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| NOVOCURE LIMITED                                                           | NOVOCURE LTD                                      | CUSIP: G6674U108<br>LEI: 213800YPP55UMHWA4826 | Long             | EC               | CORP              | JE        |     65257 | NS      | $5950133.26   | 0.18%             |  |  |  | No            |                  1 | On Loan: —       |
| SIGNIFY HEALTH, INC.                                                       | SIGNIFY HEALTH INC                                | CUSIP: 82671G100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51373 | NS      | $1462075.58   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| ENCOMPASS HEALTH CORPORATION                                               | ENCOMPASS HEALTH CORP                             | CUSIP: 29261A100<br>LEI: 549300FVRPM9DRQZRG64 | Long             | EC               | CORP              | US        |     62097 | NS      | $3877957.65   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| BIO-TECHNE CORPORATION                                                     | BIO TECHNE CORP                                   | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |     98386 | NS      | $7837428.76   | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| REPLIGEN CORPORATION                                                       | REPLIGEN CORP                                     | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |     34956 | NS      | $6477346.80   | 0.20%             |  |  |  | No            |                  1 | On Loan: —       |
| CHEMED CORPORATION                                                         | CHEMED CORP                                       | CUSIP: 16359R103<br>LEI: 54930020031IDJT2IM79 | Long             | EC               | CORP              | US        |      9228 | NS      | $4661431.92   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| CENTENE CORPORATION                                                        | CENTENE CORPORATION                               | CUSIP: 15135B101<br>LEI: 549300Z7JJ4TQSQGT333 | Long             | EC               | CORP              | US        |    359664 | NS      | $27420783.36  | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY                                | JAZZ PHARMACEUTICALS PLC                          | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     38865 | NS      | $6088590.90   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| NATERA, INC.                                                               | NATERA INC                                        | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     61991 | NS      | $2661273.63   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| HENRY SCHEIN, INC.                                                         | HENRY SCHEIN INC                                  | CUSIP: 806407102<br>LEI: VGO3WGL8H45T73F4RR92 | Long             | EC               | CORP              | US        |     85393 | NS      | $7356606.95   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| OAK STREET HEALTH, INC.                                                    | OAK STREET HEALTH INC                             | CUSIP: 67181A107<br>LEI: 2549007CJE6GSEURLA30 | Long             | EC               | CORP              | US        |     73644 | NS      | $2140094.64   | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| INCYTE CORPORATION                                                         | INCYTE CORPORATION                                | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |    115395 | NS      | $9824730.30   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| MEDTRONIC PUBLIC LIMITED COMPANY                                           | MEDTRONIC PLC                                     | CUSIP: G5960L103<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    846159 | NS      | $70815046.71  | 2.15%             |  |  |  | No            |                  1 | On Loan: No      |
| LABORATORY CORPORATION OF AMERICA HOLDINGS                                 | LABORATORY CORP OF AMERICA HOLDINGS               | CUSIP: 50540R409<br>LEI: OZ7UA8IXAIFILY2VZH07 | Long             | EC               | CORP              | US        |     56006 | NS      | $14120232.72  | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| ABBVIE INC.                                                                | ABBVIE INC                                        | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |   1118878 | NS      | $165314224.50 | 5.03%             |  |  |  | No            |                  1 | On Loan: No      |
| AVANTOR, INC.                                                              | AVANTOR INC                                       | CUSIP: 05352A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    385438 | NS      | $9211968.20   | 0.28%             |  |  |  | No            |                  1 | On Loan: —       |
| DANAHER CORPORATION                                                        | DANAHER CORP                                      | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    409816 | NS      | $108347154.08 | 3.30%             |  |  |  | No            |                  1 | On Loan: No      |
| MODERNA, INC.                                                              | MODERNA INC                                       | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |    210042 | NS      | $36979994.52  | 1.12%             |  |  |  | No            |                  1 | On Loan: —       |
| GLOBUS MEDICAL, INC.                                                       | GLOBUS MEDICAL INC                                | CUSIP: 379577208<br>LEI: 5299003M2P4CIK0RF205 | Long             | EC               | CORP              | US        |     48469 | NS      | $3659409.50   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| ELANCO ANIMAL HEALTH INCORPORATED                                          | ELANCO ANIMAL HEALTH INC                          | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |    281183 | NS      | $3860642.59   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares      | BLACKROCK CASH FUNDS TREASURY                     | CUSIP: 066922477<br>LEI: N/A                  | Long             | STIV             | RF                | US        |   4324609 | NS      | $4324609.02   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| DAVITA INC.                                                                | DAVITA INC                                        | CUSIP: 23918K108<br>LEI: M2XHYMU3TZNEZURC6H66 | Long             | EC               | CORP              | US        |     35300 | NS      | $2908367.00   | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| INTUITIVE SURGICAL, INC.                                                   | INTUITIVE SURGICAL INC                            | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |    223013 | NS      | $54792063.97  | 1.67%             |  |  |  | No            |                  1 | On Loan: No      |
| CARDINAL HEALTH, INC.                                                      | CARDINAL HEALTH INC                               | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |    165728 | NS      | $12802488.00  | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| VIATRIS INC.                                                               | VIATRIS INC                                       | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    766319 | NS      | $9318439.04   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| BIO-RAD LABORATORIES, INC.                                                 | BIO RAD LABORATORIES INC                          | CUSIP: 090572207<br>LEI: 549300ZC1GPV35XYDK53 | Long             | EC               | CORP              | US        |     13525 | NS      | $6322396.50   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| ILLUMINA, INC.                                                             | ILLUMINA INC                                      | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |     99433 | NS      | $21298548.60  | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| TELADOC HEALTH, INC.                                                       | TELADOC HEALTH INC                                | CUSIP: 87918A105<br>LEI: 549300I2PVFBC9MFAC61 | Long             | EC               | CORP              | US        |    101535 | NS      | $2985129.00   | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| GUARDANT HEALTH, INC.                                                      | GUARDANT HEALTH INC                               | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     61536 | NS      | $1934076.48   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| AMGEN INC.                                                                 | AMGEN INC                                         | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |    338050 | NS      | $85323820.00  | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| RESMED INC.                                                                | RESMED INC                                        | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |     91386 | NS      | $20869820.82  | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| GE HEALTHCARE TECHNOLOGIES INC.                                            | GE HEALTHCARE TECHNOLOGIES INC                    | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |    229985 | NS      | $15988557.20  | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| MOLINA HEALTHCARE, INC.                                                    | MOLINA HEALTHCARE INC                             | CUSIP: 60855R100<br>LEI: 549300NQQCEQ46YHZ591 | Long             | EC               | CORP              | US        |     36226 | NS      | $11296353.58  | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| WEST PHARMACEUTICAL SERVICES, INC.                                         | WEST PHARMACEUTICAL SERVICES INC                  | CUSIP: 955306105<br>LEI: 5493007NKRGM1RJQ1P16 | Long             | EC               | CORP              | US        |     46834 | NS      | $12439110.40  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.                             | CHARLES RIVER LABORATORIES INTERNATIONAL INC      | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |     31884 | NS      | $7755783.00   | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| NOVAVAX, INC.                                                              | NOVAVAX INC                                       | CUSIP: 670002401<br>LEI: 529900J4GJHPEPQ23205 | Long             | EC               | CORP              | US        |     49345 | NS      | $538353.95    | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| ENOVIS CORPORATION                                                         | ENOVIS CORP                                       | CUSIP: 194014502<br>LEI: 635400OP2DYYYMOIYL17 | Long             | EC               | CORP              | US        |     32005 | NS      | $2014714.75   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| UNITEDHEALTH GROUP INCORPORATED                                            | UNITEDHEALTH GROUP INC                            | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    592165 | NS      | $295602846.35 | 8.99%             |  |  |  | No            |                  1 | On Loan: No      |
| CATALENT, INC.                                                             | CATALENT INC                                      | CUSIP: 148806102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    112862 | NS      | $6043760.10   | 0.18%             |  |  |  | No            |                  1 | On Loan: —       |
| BRUKER CORPORATION                                                         | BRUKER CORP                                       | CUSIP: 116794108<br>LEI: LEBZ6VLQ6I8XB1NHVY15 | Long             | EC               | CORP              | US        |     67571 | NS      | $4738078.52   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| ALIGN TECHNOLOGY, INC.                                                     | ALIGN TECHNOLOGY INC                              | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |     49588 | NS      | $13375371.24  | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                                              | ULTRAGENYX PHARMACEUTICAL INC                     | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     42229 | NS      | $1914240.57   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| SYNEOS HEALTH, INC.                                                        | SYNEOS HEALTH INC                                 | CUSIP: 87166B102<br>LEI: 549300F1ZGKDS8P6GU13 | Long             | EC               | CORP              | US        |     64859 | NS      | $2329735.28   | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| CIGNA CORPORATION                                                          | CIGNA CORP                                        | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |    189491 | NS      | $60006114.97  | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| EDWARDS LIFESCIENCES CORPORATION                                           | EDWARDS LIFESCIENCES CORP                         | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    390951 | NS      | $29985941.70  | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Doximity Inc                                                               | DOXIMITY INC                                      | CUSIP: 26622P107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     70939 | NS      | $2502018.53   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| PERRIGO COMPANY PUBLIC LIMITED COMPANY                                     | PERRIGO CO PLC                                    | CUSIP: G97822103<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |     85131 | NS      | $3185602.02   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| TANDEM DIABETES CARE, INC.                                                 | TANDEM DIABETES CARE INC                          | CUSIP: 875372203<br>LEI: 549300JEPFOD0K4D3I05 | Long             | EC               | CORP              | US        |     40351 | NS      | $1643899.74   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| BAXTER INTERNATIONAL INC.                                                  | BAXTER INTERNATIONAL INC                          | CUSIP: 071813109<br>LEI: J5OIVXX3P24RJRW5CK77 | Long             | EC               | CORP              | US        |    318427 | NS      | $14548929.63  | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| THERMO FISHER SCIENTIFIC INC.                                              | THERMO FISHER SCIENTIFIC INC                      | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |    247706 | NS      | $141274162.98 | 4.30%             |  |  |  | No            |                  1 | On Loan: No      |
| THE COOPER COMPANIES, INC.                                                 | COOPER COS INC                                    | CUSIP: 216648402<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |     30724 | NS      | $10720525.32  | 0.33%             |  |  |  | No            |                  1 | On Loan: —       |
| BIOMARIN PHARMACEUTICAL INC.                                               | BIOMARIN PHARMACEUTICAL INC                       | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |    116706 | NS      | $13462037.10  | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Enhabit Inc                                                                | ENHABIT INC                                       | CUSIP: 29332G102<br>LEI: 549300RFQ78SLDFSHF49 | Long             | EC               | CORP              | US        |     31048 | NS      | $476897.28    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| QUIDELORTHO CORPORATION                                                    | QUIDELORTHO CORP                                  | CUSIP: 219798105<br>LEI: 549300YU8CMO9HF53113 | Long             | EC               | CORP              | US        |     30827 | NS      | $2639099.47   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| EXACT SCIENCES CORPORATION                                                 | EXACT SCIENCES CORP                               | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |    110475 | NS      | $7459272.00   | 0.23%             |  |  |  | No            |                  1 | On Loan: —       |
| DENTSPLY SIRONA INC.                                                       | DENTSPLY SIRONA INC                               | CUSIP: 24906P109<br>LEI: 9NHEHR1SOZCYXDO8HO28 | Long             | EC               | CORP              | US        |    135496 | NS      | $4990317.68   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| ENVISTA HOLDINGS CORPORATION                                               | ENVISTA HOLDINGS CORP                             | CUSIP: 29415F104<br>LEI: 549300BX623VURJZ5269 | Long             | EC               | CORP              | US        |    102909 | NS      | $4012421.91   | 0.12%             |  |  |  | No            |                  1 | On Loan: —       |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION                                  | INTEGRA LIFESCIENCES HOLDINGS CORP                | CUSIP: 457985208<br>LEI: WB7IJCYY8YFTENS4O147 | Long             | EC               | CORP              | US        |     45550 | NS      | $2610015.00   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| PENUMBRA, INC.                                                             | PENUMBRA INC                                      | CUSIP: 70975L107<br>LEI: 549300RGE06P3ECANU72 | Long             | EC               | CORP              | US        |     22542 | NS      | $5644742.22   | 0.17%             |  |  |  | No            |                  1 | On Loan: —       |
| TENET HEALTHCARE CORPORATION                                               | TENET HEALTHCARE CORP                             | CUSIP: 88033G407<br>LEI: 0W9AIBT6U6ADJ2I8HK17 | Long             | EC               | CORP              | US        |     67209 | NS      | $3686413.65   | 0.11%             |  |  |  | No            |                  1 | On Loan: —       |
| PREMIER, INC.                                                              | PREMIER INC                                       | CUSIP: 74051N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     74562 | NS      | $2487388.32   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| PERKINELMER, INC.                                                          | PERKINELMER INC                                   | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |     79770 | NS      | $10970768.10  | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| ROYALTY PHARMA PLC                                                         | ROYALTY PHARMA PLC                                | CUSIP: G7709Q104<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    235214 | NS      | $9218036.66   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| ALNYLAM PHARMACEUTICALS, INC.                                              | ALNYLAM PHARMACEUTICALS INC                       | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     77741 | NS      | $17600562.40  | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| BECTON, DICKINSON AND COMPANY                                              | BECTON DICKINSON CO                               | CUSIP: 075887109<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | EC               | CORP              | US        |    179743 | NS      | $45334779.46  | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| TELEFLEX INCORPORATED                                                      | TELEFLEX INC                                      | CUSIP: 879369106<br>LEI: UUL85LWXB4NGSWWXIQ25 | Long             | EC               | CORP              | US        |     29672 | NS      | $7222758.24   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| VERTEX PHARMACEUTICALS INCORPORATED                                        | VERTEX PHARMACEUTICALS INC                        | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |    161875 | NS      | $52301812.50  | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| BIOGEN INC.                                                                | BIOGEN INC                                        | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     90671 | NS      | $26376193.90  | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| DEXCOM, INC.                                                               | DEXCOM INC                                        | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |    243797 | NS      | $26108220.73  | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| ABBOTT LABORATORIES                                                        | ABBOTT LABORATORIES                               | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |   1085575 | NS      | $120010316.25 | 3.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Azenta, Inc.                                                               | AZENTA INC                                        | CUSIP: 114340102<br>LEI: 35ZN6X1ANPH25YN32Y17 | Long             | EC               | CORP              | US        |     47001 | NS      | $2627355.90   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| ELEVANCE HEALTH, INC.                                                      | ELEVANCE HEALTH INC                               | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |    152606 | NS      | $76301473.94  | 2.32%             |  |  |  | No            |                  1 | On Loan: No      |
| QUEST DIAGNOSTICS INCORPORATED                                             | QUEST DIAGNOSTICS INC                             | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |     71786 | NS      | $10658785.28  | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| ELI LILLY AND COMPANY                                                      | ELI LILLY CO                                      | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    533437 | NS      | $183582343.55 | 5.58%             |  |  |  | No            |                  1 | On Loan: No      |
| VEEVA SYSTEMS INC.                                                         | VEEVA SYSTEMS INC                                 | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |     88135 | NS      | $15031424.25  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| HUMANA INC.                                                                | HUMANA INC                                        | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |     80019 | NS      | $40945722.30  | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| GILEAD SCIENCES, INC.                                                      | GILEAD SCIENCES INC                               | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    794695 | NS      | $66706698.30  | 2.03%             |  |  |  | No            |                  1 | On Loan: No      |
| XAV HEALTH CARE MAR23                                                      | XAV HEALTH CARE MAR23                             | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |        60 | NC      | $-248868.85   | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| HCA HEALTHCARE, INC.                                                       | HCA HEALTHCARE INC                                | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |    136572 | NS      | $34835420.04  | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X Genomics Inc                                                           | 10X GENOMICS INC                                  | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |     58435 | NS      | $2736511.05   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| AMEDISYS, INC.                                                             | AMEDISYS INC                                      | CUSIP: 023436108<br>LEI: 5299001RBS9GK9STN379 | Long             | EC               | CORP              | US        |     20356 | NS      | $1967610.96   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| IONIS PHARMACEUTICALS, INC.                                                | IONIS PHARMACEUTICALS INC                         | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |     89528 | NS      | $3569481.36   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| JOHNSON & JOHNSON                                                          | JOHNSON JOHNSON                                   | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |   1666141 | NS      | $272280762.22 | 8.28%             |  |  |  | No            |                  1 | On Loan: No      |
| HOLOGIC, INC.                                                              | HOLOGIC INC                                       | CUSIP: 436440101<br>LEI: 549300DYP6F5ZJL0LB74 | Long             | EC               | CORP              | US        |    155558 | NS      | $12657754.46  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| STRYKER CORPORATION                                                        | STRYKER CORP                                      | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |    222413 | NS      | $56450643.53  | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCK & CO., INC.                                                          | MERCK CO INC                                      | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |   1601516 | NS      | $172018833.56 | 5.23%             |  |  |  | No            |                  1 | On Loan: No      |
| PFIZER INC.                                                                | PFIZER INC                                        | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   3578161 | NS      | $158011589.76 | 4.81%             |  |  |  | No            |                  1 | On Loan: No      |
| SEAGEN INC.                                                                | SEAGEN INC                                        | CUSIP: 81181C104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     85979 | NS      | $11992350.92  | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| BRISTOL-MYERS SQUIBB COMPANY                                               | BRISTOL MYERS SQUIBB CO                           | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |   1348278 | NS      | $97952396.70  | 2.98%             |  |  |  | No            |                  1 | On Loan: No      |
| AGILON HEALTH, INC.                                                        | AGILON HEALTH INC                                 | CUSIP: 00857U107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    119992 | NS      | $2611025.92   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| ORGANON & CO.                                                              | ORGANON CO                                        | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    160630 | NS      | $4839781.90   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX LABORATORIES, INC.                                                   | IDEXX LABORATORIES INC                            | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |     51991 | NS      | $24981675.50  | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| ZOETIS INC.                                                                | ZOETIS INC                                        | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    298063 | NS      | $49326445.87  | 1.50%             |  |  |  | No            |                  1 | On Loan: No      |
| BOSTON SCIENTIFIC CORPORATION                                              | BOSTON SCIENTIFIC CORP                            | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    903254 | NS      | $41775497.50  | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA HOLDINGS INC                                                         | IQVIA HOLDINGS INC                                | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |    117349 | NS      | $26921034.09  | 0.82%             |  |  |  | No            |                  1 | On Loan: —       |
| Ginkgo Bioworks Holdings Inc                                               | GINKGO BIOWORKS HOLDINGS INC                      | CUSIP: 37611X100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    552528 | NS      | $1077429.60   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Qiagen N.V.                                                                | QIAGEN NV                                         | CUSIP: N72482123<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |    143363 | NS      | $7024787.00   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| SAREPTA THERAPEUTICS, INC.                                                 | SAREPTA THERAPEUTICS INC                          | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |     53212 | NS      | $6649903.64   | 0.20%             |  |  |  | No            |                  1 | On Loan: —       |
| NEUROCRINE BIOSCIENCES, INC.                                               | NEUROCRINE BIOSCIENCES INC                        | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     59930 | NS      | $6648034.90   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY                                | HORIZON THERAPEUTICS PLC                          | CUSIP: G46188101<br>LEI: 529900P0GSQ79OOZEV53 | Long             | EC               | CORP              | IE        |    140001 | NS      | $15360909.72  | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| INSULET CORPORATION                                                        | INSULET CORP                                      | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |     43520 | NS      | $12504166.40  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Certara Inc                                                                | CERTARA INC                                       | CUSIP: 15687V109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     73493 | NS      | $1425764.20   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| UNIVERSAL HEALTH SERVICES, INC.                                            | UNIVERSAL HEALTH SERVICES                         | CUSIP: 913903100<br>LEI: 549300YGMGQDO0NMJD09 | Long             | EC               | CORP              | US        |     39149 | NS      | $5802273.29   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| MASIMO CORPORATION                                                         | MASIMO CORP                                       | CUSIP: 574795100<br>LEI: 549300Q4A8JK0PIYCU29 | Long             | EC               | CORP              | US        |     30110 | NS      | $5121108.80   | 0.16%             |  |  |  | No            |                  1 | On Loan: —       |
| Mirati Therapeutics Inc                                                    | MIRATI THERAPEUTICS INC                           | CUSIP: 60468T105<br>LEI: 529900GYRW59IDQV6N54 | Long             | EC               | CORP              | US        |     28321 | NS      | $1512624.61   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| ZIMMER BIOMET HOLDINGS, INC.                                               | ZIMMER BIOMET HOLDINGS INC                        | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |    132696 | NS      | $16897508.64  | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Maravai LifeSciences Holdings Inc                                          | MARAVAI LIFESCIENCES HOLDINGS INC                 | CUSIP: 56600D107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     70059 | NS      | $1027064.94   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| ICU MEDICAL, INC.                                                          | ICU MEDICAL INC                                   | CUSIP: 44930G107<br>LEI: 5493003NRW7LS2QZRH60 | Long             | EC               | CORP              | US        |     12834 | NS      | $2479913.82   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| AGILENT TECHNOLOGIES, INC.                                                 | AGILENT TECHNOLOGIES INC                          | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |    187116 | NS      | $28456601.28  | 0.87%             |  |  |  | No            |                  1 | On Loan: —       |
| EXELIXIS, INC.                                                             | EXELIXIS INC                                      | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |    199786 | NS      | $3520229.32   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| SOTERA HEALTH COMPANY                                                      | SOTERA HEALTH CO                                  | CUSIP: 83601L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     62177 | NS      | $1071931.48   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| ACADIA HEALTHCARE COMPANY, INC.                                            | ACADIA HEALTHCARE CO INC                          | CUSIP: 00404A109<br>LEI: 5493005CW985Y9D0NC11 | Long             | EC               | CORP              | US        |     56306 | NS      | $4730830.12   | 0.14%             |  |  |  | No            |                  1 | On Loan: —       |
| UNITED THERAPEUTICS CORPORATION                                            | UNITED THERAPEUTICS CORP                          | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     28198 | NS      | $7420867.66   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-03-02

**Name of Applicant:** iShares Trust

**Signature:** Chuck Pulsfort

**Name of Signer:** Chuck Pulsfort

**Title:** Assistant Treasurer